Background: A higher risk of urolithiasis has been reported in gout patients. However, whether urate-lowering treatments, including both xanthine oxidase inhibotors and uricosuric agents, are beneficial to reduce the risk or urolithiasis in gout patients has not been examined. Objectives: To investigate the independent associations between urate-lowering treatment (ULT) and the risk of urolithiasis in incident gout patients. Methods: We conducted a nested case-control study based on the Taiwan National Health Insurance Research Database (NHIRD), which was used to identify 473,858 newly diagnosis gout patients during the period from January 1, 2000 through December 31, 2004. All these patients were followed until December 31, 2013. We considered patients who first diagnose incident urolithiasis after the date of entry cohort (gout onset) as cases and the diagnostic date was defined as index date. Each case was matched up to five eligible controls whose follow-up period included the case's index date by sex, birth of year and gout diagnosis year. And the index date of case was assigned to the matched controls. Odds ratios (ORs) and 95% confidence interval (CI) of urolithiasis associated with cumulative defined daily dose (cDDD) of xanthine oxidase inhibitor and uricosuric agents were main ourcome measures. Results: Gout patients with incident urolithiasis (n=32,654) occurring after the initial diagnosis of gout aged 20-79 were age-and sex-matched 1:5 to 163,270 gout patients without urolithiasis. After adjusting for age, sex, urbanization status, income, occupation, and pertinent drugs and comorbidities, the OR of urolithiasis associated with use of ULT among gout patients were 1.04 (95% CI 1.00 to 1. 
THU0404 SELF-REPORTED SEVERITY OF GOUT IN A PRIMARY CARE SETTING AND ASSOCIATED FACTORS -RESULTS FROM A GOUT SURVEY IN PRIMARY CARE
A.J. Landgren, M. Dehlin, U. Bergsten, V. Sigurdardottir, P. Drivelegka, T. Zverkova Sandström, L. Jacobsson. Department of Rheumatology and Inflammation Research, Institution of Medicine, Sahlgrenska Academy. University of Gothenburg., Gothenburg, Sweden Background: Patients with gout are usually seen in primary care. There are numerous reports regarding severity of gout in cohort studies and patients seen in more specialized care, less is known about the spectrum of severity of the disease in primary care. Objectives: To describe the pattern of self-reported disease severity of gout and predictors thereof in a primary care setting. Methods: All patients above 18 with an ICD10-diagnosis of gout at a health care visit in primary care (Jan 2015 through Aug 2016) were identified from primary care within the Western Sweden Health Care Region (WSHCR). 941 patients were identified and included in the study. They were sent a questionnaire with questions regarding comorbidities, demographics, gout characteristics and Health Assessment questionnaire (HAQ) reflecting disability. Self-reported disease severity was assessed by a three-level Likert scale (mild, moderate, severe). Possibly associated factors were analyzed by bivariate logistic regression (binary outcome: mild vs. moderate/severe) models and factors that were statistically significant were further analyzed by multivariate analysis. Results: The response rate was 54%. Response rates were significantly lower in women overall and in men under the age of 50. Covariates that were significantly associated with more severe self-reported severity of gout in the bivariate logistic regression models (Table 1) were: female sex, hyperlipidemia, higher number of previous attacks, attack during last month, HAQ. In the multivariate analysis objective measures of gout severity such as more than ten previous attacks and attack during last month were strongly associated with the patients grading of severity, in addition to presence of hyperlipidemia (Table 1) . The Dietary Approaches to Stop Hypertension (DASH) diet, which reduces blood pressure and is recommended in cardiovascular disease (CVD) (1,2), has also been found to lower serum uric acid (SUA) levels, particularly among those with hyperuricemia (3). Thus, the DASH diet may be particularly useful in gout care by reducing both SUA and CVD risk, especially among patients with hypertension which affects 74% of gout patients (4), thereby "killing two birds with one stone". However, corresponding data for the risk of gout are not available. In contrast, a Western dietary pattern may increase the risk of gout. Objectives: To prospectively examine the relation between the DASH and Western dietary patterns and the risk of gout among men. Methods: Using the Health Professionals Follow-up Study, we prospectively examined the relation between the DASH and Western diets and incident gout in 44,444 male participants with no history of gout at baseline. Using validated food frequency questionnaires, each participant was assigned a DASH score (reflecting high intake of fruits, vegetables, nuts and legumes, low-fat dairy products, and whole grains, and low intake of sodium, sweetened beverages, and red and processed meats) and a Western pattern score (reflecting higher intake of red and processed meats, French fries, refined grains, sweets, and desserts). We identified incident cases of gout meeting the preliminary ACR survey criteria for gout, adjusting for potential confounders including age, total energy intake, body mass index (BMI), diuretic use, history of hypertension, history of renal failure, and intake of alcohol and coffee. We conducted stratified analyses to evaluate whether the association between the DASH Table 1) . These associations persisted regardless of BMI, alcohol use, and hypertension status, and there was no significant interaction with these variables (all P for interaction >0.17).
